Published in Gene Therapy Weekly, November 9th, 2006
"We found that the U6 promoter is more efficient than the H1 promoter for shRNA expression and for reducing expression of CCR5 in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.